In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 286.2 | 218.8 | 209.1 | 206.9 | 169.4 | 138.9 | 127.8 |
Interest income on investments | 35.0 | 20.9 | 16.7 | 15.3 | 14.3 | 11.0 | 9.9 |
| 326.6 | 241.7 | 228.7 | 227.1 | 188.1 | 152.6 | 139.2 |
Interest expense: |
Interest on deposits | 33.5 | 13.4 | 27.2 | 44.7 | 29.7 | 19.3 | 15.3 |
Interest on borrowings | 9.4 | 4.7 | 5.9 | 8.1 | 4.4 | 2.4 | 2.7 |
| 51.3 | 25.4 | 37.2 | 53.4 | 34.6 | 22.3 | 18.5 |
Net interest income | 275.3 | 216.3 | 191.5 | 173.7 | 153.5 | 130.3 | 120.7 |
Provision for loan losses | 24.7 | -10.8 | 59.9 | 9.6 | 1.0 | 8.3 | 30.1 |
Net interest income after provision for loan losses | 250.6 | 227.0 | 131.6 | 164.1 | 152.4 | 122.0 | 90.6 |
Other non-interest income | 57.3 | 62.2 | 64.7 | 46.5 | 41.2 | 29.2 | 41.9 |
Total non-interest income | 57.3 | 62.2 | 64.7 | 46.5 | 41.2 | 29.2 | 41.9 |
Non-interest expenses | 200.4 | 156.8 | 151.9 | 144.1 | 131.2 | 130.7 | 116.7 |
Equity in earnings | -0.2 | 5.7 | 0.1 | 0.0 | 0.8 | 0.4 | |
Pre-tax income before non-recurring items | 113.4 | 132.2 | 43.1 | 66.2 | 62.3 | 31.5 | 15.8 |
Non-recurring items | 6.0 | | | | | 11.0 | |
Asset impairment | | -0.2 | -1.2 | -0.3 | -0.2 | | |
Pre-tax income | 107.4 | 132.4 | 44.4 | 66.5 | 62.4 | 20.5 | 15.8 |
Income taxes | 19.7 | 23.9 | 8.0 | 12.7 | 10.8 | 5.8 | 2.9 |
Tax rate | 18.4% | 18.0% | 18.0% | 19.0% | 17.4% | 28.4% | 18.5% |
Net income | 87.7 | 108.5 | 36.4 | 53.9 | 48.7 | 9.8 | 8.1 |
Net margin | 28.5% | 37.5% | 18.5% | 25.6% | 25.1% | 6.5% | 6.1% |
|
Basic EPS | $3.29 | $4.63 | $1.56 | $2.30 | $2.21 | $0.51 | $0.46 |
Diluted EPS | $3.28 | $4.60 | $1.55 | $2.28 | $2.19 | $0.50 | $0.46 |
|
Shares outstanding (basic) | 26.6 | 23.4 | 23.4 | 23.5 | 22.0 | 19.4 | 17.5 |
Shares outstanding (diluted) | 26.8 | 23.6 | 23.5 | 23.7 | 22.2 | 19.6 | 17.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |